Correlation Between Verve Therapeutics and Repligen

Can any of the company-specific risk be diversified away by investing in both Verve Therapeutics and Repligen at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Verve Therapeutics and Repligen into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Verve Therapeutics and Repligen, you can compare the effects of market volatilities on Verve Therapeutics and Repligen and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Verve Therapeutics with a short position of Repligen. Check out your portfolio center. Please also check ongoing floating volatility patterns of Verve Therapeutics and Repligen.

Diversification Opportunities for Verve Therapeutics and Repligen

0.38

Correlation Coefficient

Verve Therapeutics  Repligen

Weak diversification

The 3 months correlation between Verve and Repligen is 0.38. Overlapping area represents the amount of risk that can be diversified away by holding Verve Therapeutics and Repligen in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Repligen and Verve Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Verve Therapeutics are associated (or correlated) with Repligen. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Repligen has no effect on the direction of Verve Therapeutics i.e., Verve Therapeutics and Repligen go up and down completely randomly.

Pair Corralation between Verve Therapeutics and Repligen

Given the investment horizon of 90 days Verve Therapeutics is expected to under-perform the Repligen. In addition to that, Verve Therapeutics is 1.42 times more volatile than Repligen. It trades about -0.03 of its total potential returns per unit of risk. Repligen is currently generating about 0.01 per unit of volatility. If you would invest  15,093  in Repligen on August 30, 2024 and sell it today you would lose (94.00) from holding Repligen or give up 0.62% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Verve Therapeutics  vs.  Repligen

Verve Therapeutics

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Verve Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest uncertain performance, the Stock's basic indicators remain stable and the latest fuss on Wall Street may also be a sign of long-term gains for the venture sophisticated investors.

Repligen

Risk-Adjusted Performance

1 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Repligen are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of very healthy technical and fundamental indicators, Repligen is not utilizing all of its potentials. The latest stock price disarray, may contribute to short-term losses for the investors.

Pair Trading with Verve Therapeutics and Repligen

The main advantage of trading using opposite Verve Therapeutics and Repligen positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Verve Therapeutics position performs unexpectedly, Repligen can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Repligen will offset losses from the drop in Repligen's long position.

The idea behind Verve Therapeutics and Repligen pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..